A Randomized, Placebo-controlled Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C

Condition:   Cardiogenic Shock Interventions:   Drug: Istaroxime;   Drug: Placebo Sponsors:   Windtree Therapeutics;   Momentum Research, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials